Arboretum Ventures is an investment fund managing more than $53.6 billion ran by Marcy Marshall. There are currently 3 companies in Mrs. Marshall’s portfolio. The largest investments include Eqrx Inc and Pear Therapeutics Inc, together worth $47.1 billion.
As of 18th January 2023, Arboretum Ventures’s top holding is 13,935,623 shares of Eqrx Inc currently worth over $34.3 billion and making up 64.0% of the portfolio value.
In addition, the fund holds 10,859,050 shares of Pear Therapeutics Inc worth $12.8 billion.
The third-largest holding is Inogen Inc worth $6.5 billion.
Currently, Arboretum Ventures's portfolio is worth at least $53.6 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Arboretum Ventures office and employees reside in Ann Arbor, Michigan. According to the last 13-F report filed with the SEC, Marcy Marshall serves as the Chief Financial Officer at Arboretum Ventures.
The two most similar investment funds to Arboretum Ventures are Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and D. E. Shaw & Co. They manage $53.4 billion and $54.1 billion respectively.
Arboretum Ventures’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 12.1% of
the total portfolio value.
The fund focuses on investments in the United States as
33.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $465 million.
These positions were updated on January 25th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Eqrx Inc |
No change
13,935,623
|
$34,281,633,000 | 63.96% |
| Pear Therapeutics Inc |
No change
10,859,050
|
$12,813,679,000 | 23.91% |
| Inogen Inc |
No change
330,000
|
$6,504,300,000 | 12.13% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||